Pharmavoice Podcasts

Date Posted: 6/27/2011Size: 6.37MBLength: 00:13:55Thought Leader: Gary Bartolacci, Senior Account Director, Kantar HealthIn this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 5/31/2011Size: 7.8MBLength: 00:17:03Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical ServicesIn this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 5/31/2011Size: 5.56MBLength: 00:12:09Thought Leader: Tim Dietlin, VP of Alliance Development, INC ResearchIn this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 4/29/2011Size: 7.95MBLength: 00:17:23Thought Leader: Richard Scarbath , Director, Enterprise Accounts, AngelIn this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 4/29/2011Size: 12.0MBLength: 00:26:17Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical ServicesIn this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 3/30/2011Size: 5.95MBLength: 00:13:02Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 1/31/2011Size: 8.78MBLength: 00:19:11Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar HealthIn this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.Play PodcastDownload transcript and white paperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 12/30/2010Size: 6.12MBLength: 00:13:48Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar HealthIn this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.Play PodcastDownload transcript and white paperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 3/24/2011Size: 7.68MBLength: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher ScientificIn this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 3/4/2011Size: 6.78MBLength: 00:14:49Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPPIn this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 3/1/2011Size: 7.4MBLength: 00:16:10Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharmIn this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 1/31/2011Size: 4.63MBLength: 00:10:07Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, CognizantIn this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 1/31/2011Size: 8.04MBLength: 00:17:34Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, AptuitIn this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 1/31/2011Size: 5.97MBLength: 00:13:03Thought Leader: James DeSanti, CEO, PharmaVigilantIn this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 07/29/2010Size: 6.64MBLength: 00:14:31Thought Leaders: Ed Jahn, Clinical Operations Specialist, Criterium and Jaime Campbell Hudak, Clinical Data Liaison II, CriteriumIn this episode, our thought leaders discuss ways for CROs and sites to work together to achieve the best possible results. This episode is chock full of best practices and tips, as well as an overview of the results of a July 2010 survey of sites.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 12/17/2010Size: 4.92MBLength: 00:10:45Thought Leader: James DeSanti, CEO, PharmaVigilantIn this episode, Mr. DeSanti discusses remote source document verification, also known as rSDV. First we'll define rSDV, and then talk about the benefits, challenges, and the ROI of implementing rSDV, as well as other issues.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 9/30/2010Size: 7.93MBLength: 00:17:19Thought Leader: James DeSanti, CEO, PharmaVigilantIn this episode, Mr. DeSanti discusses the clinical trials trend of moving to an Electronic Trial Master File platform. He covers the strategic and practical aspects of making the move, and what the payback is for doing so.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 9/30/2010Size: 7.93MBLength: 00:17:19Thought Leader: Dr. Philippe Muller, Managing Director Manufacturing and Comparator Services, Fisher Clinical ServicesIn this episode, we'll discuss using comparator drugs in clinical trials, and overcoming the issues and challenges of using comparators.Play PodcastDownload related whitepaperFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 9/24/2010Size: 6.22MBLength: 00:13:35Thought Leaders: John Pelkowski, Senior Director of Client Engagement for Medical Affairs, AstraZeneca and Kevin Krause, Senior Director of Medical Affairs, Strategy & Operations, AstraZenecaIn this episode, we'll discuss AstraZeneca's recent move to the cloud. The company switched from an on-premise, custom-developed CRM system to Veeva Systems' multi-tenant SaaS CRM system.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Date Posted: 12/01/2009 Size: 14.4MB Length: 00:14:04 Thought Leader: Richard Malcolm Ph.D., CEO, AcurianDr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.Play PodcastFor more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.